Depot investor denounces ‘poison pill’

Office Depot's largest common shareholder has hit out at the company's move to adopt a 'poison pill' rights plan.


To continue reading this article, you must have a paid membership.

Join now from just £5

Existing paying members, please log in to access the full story.


If you are not a paying member, sign up now: